Lv1
13 积分 2020-09-27 加入
Survival outcomes and safety of nimotuzumab combined with radiotherapy ± chemotherapy for locally advanced cervical cancer
21天前
已完结
A phase I clinical trial of radiation therapy, durvalumab and tremelimumab in recurrent gynecologic cancer
22天前
已完结
Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses
22天前
已完结
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study
22天前
已完结
Adjuvant Chemoradiotherapy vs Radiotherapy Alone for Patients With Intermediate-Risk Cervical Cancer
22天前
已完结
Locoregional Treatment in Patients With Metastatic Cervical Cancer: Benefit of Dose Escalation Strategies
22天前
已完结
Cancer control and toxicity results of chemoradiation for cervical cancer using a three-fraction HDR brachytherapy boost
8个月前
已关闭
Patient-Reported Outcome Measures in Clinical Research
8个月前
已完结
Patient-Reported Outcome Measures in Clinical Research
8个月前
已完结
皖公网安备34019202002308
